ArticleJACC. Advances2024

Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity.

Konstantin A Krychtiuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.